Median survival according to cell type for the UK, Australian and Dutch cohorts combined
| Cell type | Median survival in days (95% CI) | n |
|---|---|---|
| Mesothelioma | 339 (267 to 422) | 170 |
| Haematological malignancy | 218 (160 to 484) | 35 |
| Gynaecological malignancy | 203 (97 to 279) | 59 |
| Breast cancer | 192 (133 to 271) | 140 |
| Renal cell carcinoma | 114 (33 to 334) | 22 |
| Adenocarcinoma of unknown primary | 87 (13 to 286) | 11 |
| Lung cancer | 74 (60 to 92) | 215 |
| Other | 71 (46 to 102) | 33 |
| Gastrointestinal cancer | 61 (44 to 73) | 61 |
| Sarcoma | 44 (19 to 76) | 12 |
| Melanoma | 43 (23 to 72) | 23 |
| Urological cancer (bladder, prostate, testis, penile) | 33 (22 to 168) | 8 |
| Overall | 136 (119 to 167) | 789 |